Table of Contents Why patients are turning to compounded GLP-1 therapies Understanding the safety concerns of compounded GLP-1 products How to evaluate patients taking compounded GLP-1 medications Documentation, counseling, and transitioning to FDA-approved therapy Frequently Asked Questions Why Patients Are Turning to Compounded GLP-1 Therapies Several factors have fueled the rapid growth of compounded GLP-1 therapies
The experts in this story concur that microdosing weight loss meds might be safe under supervision from a licensed health care professionalbut with a giant asterisk
Conclusion The proliferation of misleading advertisements for GLP-1 RAs on social media, often from influencers & celebrities, warrants the recognition of an exception to the learned intermediary doctrine for GLP-1 RA drugs
Exendin-4 has a half-life of only 2.4 h in the blood, while semaglutide has a half-life of 165 h [207]
This causes our stomach to protrude, sometimes for a few hours and sometimes for the whole day, and can feel like food is swishing around in our stomach instead of moving through
In India, 10 generics manufacturers are already making semaglutide injectable pens, while three others are formulating it in vials to be administered with a syringe and needles